Literature DB >> 20590944

Molecular pathology of renal oncocytoma: a review.

Maria V Yusenko1.   

Abstract

Differentiating renal oncocytoma from its renal cell carcinoma (RCC) mimics, particularly chromophobe RCC, can be difficult, especially when limited tissue is available for evaluation and requires sophisticated microscopic, ultrastructural and immunohistochemical evaluation. In this review, the relevant literature has been reviewed, and supporting data obtained by applying modern microarray-based technologies are discussed with a focus on molecular pathology of renal oncocytoma. The high resolution whole-genome DNA-microarray based analyses excluded with all certainty the occurrence of small specific alterations. Renal oncocytomas are characterized by variable chromosomal patterns. The number of genes selected by global gene expression analyses and their usefulness in the diagnostic pathology based on immunohistochemical evaluation is far below the expectations. The conflicting staining patterns, together with the poor specificity of proposed antibodies, leads us to believe that these candidate immunomarkers might not help in the separation of these tumors. Applying DNA based tools might help in the diagnosis of renal oncocytoma with uncertain histology. However, only the combination of all available techniques could give reliable information.

Entities:  

Mesh:

Year:  2010        PMID: 20590944     DOI: 10.1111/j.1442-2042.2010.02574.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  20 in total

1.  Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasis.

Authors:  Jeffrey C Gahan; Miguel Gosalbez; Travis Yates; Ezekiel E Young; Diogo O Escudero; Andrew Chi; Michael Garcia-Roig; Ramgopal Satyanarayana; Mark S Soloway; Vincent G Bird; Vinata B Lokeshwar
Journal:  J Urol       Date:  2012-01-15       Impact factor: 7.450

2.  Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.

Authors:  Steffen Durinck; Eric W Stawiski; Andrea Pavía-Jiménez; Zora Modrusan; Payal Kapur; Bijay S Jaiswal; Na Zhang; Vanina Toffessi-Tcheuyap; Thong T Nguyen; Kanika Bajaj Pahuja; Ying-Jiun Chen; Sadia Saleem; Subhra Chaudhuri; Sherry Heldens; Marlena Jackson; Samuel Peña-Llopis; Joseph Guillory; Karen Toy; Connie Ha; Corissa J Harris; Eboni Holloman; Haley M Hill; Jeremy Stinson; Celina Sanchez Rivers; Vasantharajan Janakiraman; Weiru Wang; Lisa N Kinch; Nick V Grishin; Peter M Haverty; Bernard Chow; Julian S Gehring; Jens Reeder; Gregoire Pau; Thomas D Wu; Vitaly Margulis; Yair Lotan; Arthur Sagalowsky; Ivan Pedrosa; Frederic J de Sauvage; James Brugarolas; Somasekar Seshagiri
Journal:  Nat Genet       Date:  2014-11-17       Impact factor: 38.330

Review 3.  CT and MRI of small renal masses.

Authors:  Zhen J Wang; Antonio C Westphalen; Ronald J Zagoria
Journal:  Br J Radiol       Date:  2018-05-10       Impact factor: 3.039

4.  Papillary renal cell carcinoma within a renal oncocytoma: Case report of very rare coexistence.

Authors:  Cevahir Özer; Mehmet Resit Gören; Tulga Egilmez; Nebil Bal
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

5.  Low-grade oncocytic tumor of kidney harboring TSC/MTOR mutation: clinicopathologic, immunohistochemical and molecular characteristics support a distinct entity.

Authors:  Hui-Zhi Zhang; Qiu-Yuan Xia; Shu-Yan Wang; Meng-Jie Shi; Su-Ying Wang
Journal:  Virchows Arch       Date:  2022-01-31       Impact factor: 4.064

6.  Feasibility of nephron-sparing surgery in giant oncocytoma.

Authors:  Albert El Hajj; Ruban Thanigasalam; Isabelle Boulay; Vincent Molinié; Bernard Escudier; Hervé Baumert
Journal:  Can Urol Assoc J       Date:  2014 Jan-Feb       Impact factor: 1.862

Review 7.  Recent developments in the treatment of renal cell carcinoma.

Authors:  Janice P Dutcher
Journal:  Ther Adv Urol       Date:  2013-12

8.  Mutational landscape of the essential autophagy gene BECN1 in human cancers.

Authors:  Saurabh V Laddha; Shridar Ganesan; Chang S Chan; Eileen White
Journal:  Mol Cancer Res       Date:  2014-01-29       Impact factor: 5.852

9.  [¹⁸F]fluciclatide in the in vivo evaluation of human melanoma and renal tumors expressing αvβ 3 and α vβ 5 integrins.

Authors:  Esther Mena; Rikard Owenius; Baris Turkbey; Richard Sherry; Gennady Bratslavsky; Sven Macholl; Matthew P Miller; Ed J Somer; Liza Lindenberg; Stephen Adler; Joanna Shih; Peter Choyke; Karen Kurdziel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-06-28       Impact factor: 9.236

10.  Distinct Cytoplasmic Expression of KL-6 Mucin in Chromophobe Renal Cell Carcinoma: A Comparative Immunohistochemical Study with Other Renal Epithelial Cell Tumors.

Authors:  Mana Fukushima; Kayoko Higuchi; Hisashi Shimojo; Takeshi Uehara; Hiroyoshi Ota
Journal:  Acta Histochem Cytochem       Date:  2012-09-11       Impact factor: 1.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.